06/25/2025
3:34 PM | Charles River Laboratories International (Subject)
WALLMAN RICHARD F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2025
3:22 PM | Charles River Laboratories International (Issuer)
Mintz Mark (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/09/2025
3:21 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
3:40 PM | Charles River Laboratories International (Issuer)
Graves Paul W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
3:42 PM | Charles River Laboratories International (Issuer)
Enyedy Mark J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
3:45 PM | Ceesay Abraham (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
3:38 PM | Barg Steven (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
3:46 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
3:49 PM | Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
3:52 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2025
4:18 PM | Charles River Laboratories International (Issuer)
Graves Paul W (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for CRL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Charles River Laboratories International and its competitors with MarketBeat's FREE daily newsletter. |
05/29/2025
4:23 PM | Charles River Laboratories International (Issuer)
Enyedy Mark J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/29/2025
4:26 PM | Barg Steven (Reporting)
Charles River Laboratories International (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/29/2025
4:29 PM | Ceesay Abraham (Reporting)
Charles River Laboratories International (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/29/2025
3:54 PM | Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2025
3:58 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
3:08 PM | Andrews Nancy C (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
3:38 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
3:41 PM | Charles River Laboratories International (Issuer)
MASSARO GEORGE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
2:33 PM | Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/12/2025
9:44 AM | Charles River Laboratories International (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
05/07/2025
8:09 AM | Charles River Laboratories International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2025
6:08 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2025
6:15 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2025
4:44 PM | Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
8:35 AM | BlackRock, Inc. (Filed by)
Charles River Laboratories International (Subject)
| Form SCHEDULE 13G/A | |
04/02/2025
7:00 AM | Charles River Laboratories International (Filer)
| Form DEF 14A | |
04/02/2025
7:06 AM | Charles River Laboratories International (Filer)
| Form ARS | |
02/26/2025
3:18 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:36 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:38 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:41 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
3:30 PM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2025
11:36 AM | Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
8:07 AM | Charles River Laboratories International (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/19/2025
6:19 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/03/2025
4:17 PM | Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:22 PM | Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:25 PM | Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:27 PM | Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
7:04 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
This Cold War “Accident” Could Unleash New $100 Trillion AI Boom (Ad) Obscure Metal More Valuable than Gold and Bitcoin… COMBINED?
This strange "AI Metal" holds the key to the $100 trillion AI boom.
Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world.
And you won't believe what he uncovered. Click here to see the details because this could be the biggest tech story of this decade. |
12/13/2024
3:42 PM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
5:21 PM | Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
4:31 PM | BlackRock, Inc. (Filed by)
Charles River Laboratories International (Subject)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Charles River Laboratories International (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
11/07/2024
3:23 PM | Charles River Laboratories International (Subject)
WALLMAN RICHARD F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
8:16 AM | Charles River Laboratories International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
6:21 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Charles River Laboratories International (Subject)
| Form SC 13G/A | |
08/13/2024
3:17 PM | Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
3:13 PM | Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
12:34 PM | Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
8:15 AM | Charles River Laboratories International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
6:21 AM | Charles River Laboratories International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
